| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.5638 | 30 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.8995 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.0393 | 22 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.6698 | 40 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.7021 | 26 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.7549 | 26 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.6678 | 44 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.8467 | 40 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 40.0638 | 7 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.1353 | 33 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.9376 | 41 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.2757 | 19 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.6928 | 21 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.5716 | 25 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.9519 | 22 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.1194 | 14 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.956 | 37 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.6464 | 44 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.1709 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.9526 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.8846 | 31 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.5766 | 25 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.9025 | 32 |